EquityFlow
›
Companies
› InteRNA Technologies
InteRNA Technologies
Biotech
· Utrecht, NL ·
interna-technologies.com
microRNA-based cancer therapeutics
Funding history
Date
Round
Amount
Feb 2021
Series B
Dutch biotech InteRNA Technologies closed a EUR18.5M Series B led by AurorA Science, with Waterman Ventures, Aglaia Oncology Funds and OostNL.
$18.5M
Investors
Aglaia Oncology Funds
AurorA Science
OostNL
Waterman Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →